Lipocine (LPCN) Financials

$2.25

$0.00 (0.00%)

As on 10-Sep-2026 16:00EDT

Market cap

$20 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1.57	1.98	11.20	-2.85	0.50	16.14
Cost of Revenue	2.07	8.58	0.04	10.18	8.56	7.67
Gross Profit	1.54	-6.61	11.20	-13.03	-8.06	8.48
Operating Expenses	14.11	3.76	12.35	4.90	4.06	5.33
Operating Profit (EBIT)	-12.57	-10.37	-1.16	-17.93	-12.12	3.15
Other Income	--	--	--	--	--	-3.78
Profit before Tax	-11.85	-9.63	0.01	-16.35	-10.76	-0.63
Provision for Tax	0.00	0.00	0.00	0.00	0.00	0.00
Profit after Tax (Net Income)	-11.85	-9.63	0.01	-16.35	-10.76	-0.63
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-10.76	-0.63

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	21.77	14.48	21.00	20.37	35.63	45.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	0.23	1.30
Current Liabilities	2.07	2.53	1.51	2.63	1.68	5.62
Total Liabilities	25.90	17.01	22.51	23.00	37.54	52.48

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.10	0.13	0.19	0.14	3.41	6.10
Current Assets	23.74	16.88	22.32	22.86	34.14	46.38
Total Assets	25.90	17.01	22.51	23.00	37.54	52.48
Total Debt*	--	0.45	0.44	0.02	--	2.31
Net Current Assets	21.67	14.35	20.81	20.23	32.46	40.76

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-9.76	-1.22	-11.87	-11.97	-4.41
Cash Flow from Investing Activities	--	5.89	2.45	13.08	14.29	-43.78
Cash from Financing Activities	--	2.87	0.21	0.40	-2.13	26.92
Net Cash Inflow / Outflow	--	--	--	--	--	-21.27

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.86	-1.69	0.00	-3.08	-2.06	-0.12
Cash EPS ($)	--	-1.68	0.01	-3.07	-2.05	-0.12
Adjusted Book Value ($)	--	2.54	3.87	3.83	6.81	8.71
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.71	-0.23	-2.23	-2.29	-0.84
Free Cash Flow per Share ($)	--	-1.71	-0.24	-2.23	-2.31	-0.84

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-52.95	0.04	-58.38	-25.76	-1.84
ROE (%)	-65.40	-54.28	0.04	-58.40	-26.50	-2.08
ROA (%)	-51.61	-48.73	0.04	-54.02	-23.90	-1.63
EBIT Margin (%)	-755.11	-487.04	0.08	573.57	-2,146.17	-2.67
Net Margin (%)	-755.13	-487.06	0.07	573.59	-2,151.73	-5.13
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-62.70	-0.82	4.93	-6.70	-0.97	--
EBIT Growth (%)	-162.95	-106,679.26	100.06	-52.38	-2,390.30	97.61
Net Profit Growth (%)	-162.94	-115,371.85	100.05	-51.99	-1,595.88	96.97
EPS Growth (%)	-120.00	-1,096.20	1.00	-0.50	-15.94	0.98
Book Value Growth (%)	-17.23	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.76	3,168.38	-0.91	-0.19	-8.17
Price / Book Value	0.91	3.17	1.26	0.73	0.06	0.11
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	153.43	-3.28	105.06	0.44	2.84	86.23
Close Price ($)	2.56	8.03	4.88	2.79	6.76	16.85
High Price ($)	12.37	8.29	11.79	10.33	32.13	41.14
Low Price ($)	1.81	2.52	2.76	2.31	6.12	16.45
Market Cap ($ Cr)	20.20	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.02	0.00	--	0.05
Short term debt to equity ratio	--	0.03	0.02	0.00	--	0.05
Current Ratio	11.48	6.68	14.75	8.69	20.34	8.26
Quick Ratio	11.48	--	--	--	20.34	15.72
Interest Coverage	--	--	--	--	-396.00	-2.12

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	18.55	0.72	1.08	-1.83	131.97	1.53
Asset Turnover	0.07	0.10	0.49	-0.09	0.01	0.41
Receivable days	--	12.44	2.82	-45.62	331.32	2.80
Inventory Days	--	--	--	0.00	-894.56	-879.46
Payable days	--	26.46	7,409.11	35.83	40.33	68.77
Cash Conversion Cycle	--	--	--	-81.45	-603.57	-945.43

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.